The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global fish protein hydrolysate market is expected to exhibit a CAGR of 4.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Fish protein hydrolysate (FPH) is a bioactive compound produced using degraded proteins present in fish material. The compound is produced by enzymatic, acid and autolytic hydrolysis techniques, which involve decomposing minced fishes with enzymes to break down the proteins into amino acids and peptides. FPH can be produced using both salt and freshwater fishes, such as tuna, sardine, anchovy, salmon and crustacean. It is commonly used as a food binder, emulsifier, gelling agent, animal feed, cosmetic and nutritional supplement in the form of powder, paste and liquid. It is a rich source of essential fatty acids and can aid in maintaining blood pressure and cardiovascular health.
Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. FPH exhibits fast absorption properties that aid in developing lean muscle mass and reduces the risks of hypertension and high blood pressure in consumers and is thereby used extensively in sports nutrition and protein supplements. It is also used in the treatment of Irritable Bowel Syndrome (IBS) and Crohn's disease and utilized as an alternative hypoallergenic protein food for infants suffering from celiac disease and lactose and gluten intolerance. Furthermore, widespread product adoption as a cryoprotectant in aquaculture and animal feed is also catalyzing the market growth. FPH aids in preventing the outbreak of infectious diseases and immunity in animals against bacteria, fungi, viruses and parasites. Other factors, including the increasing utilization of FPH in cosmetics due to its anti-aging properties, along with rising expenditure capacities of the consumers, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global fish protein hydrolysate market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, form, fish type and application.
Breakup by Technology:
Breakup by Form:
Breakup by Fish Type:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alaska Protein Recovery LLC, Bio-marine Ingredients Ireland Ltd., Copalis, Dramm Corporation, Gelita AG, Great Pacific BioProducts Ltd., Hofseth Biocare ASA, Janatha Fish Meal & Oil Products, SAMPI, Scanbio Marine Group AS, Symrise AG and United Fisheries Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Technology, Form, Fish Type, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Alaska Protein Recovery LLC, Bio-marine Ingredients Ireland Ltd., Copalis, Dramm Corporation, Gelita AG, Great Pacific BioProducts Ltd., Hofseth Biocare ASA, Janatha Fish Meal & Oil Products, SAMPI, Scanbio Marine Group AS, Symrise AG and United Fisheries Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at